[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.198.71. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1968

Drug Mechanisms in Glaucoma.

Author Affiliations

New York

 

Edited by Gavin Paterson, PHD; S. J. H. Miller, MD, FRCS; and Gillian D. Paterson, MB. Price, $14. Pp 320, with 119 illustrations. Little, Brown & Co., 34 Beacon St, Boston 02106, 1967.

Arch Intern Med. 1968;121(5):478. doi:10.1001/archinte.1968.03640050088025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Comparatively few drugs are used in the treatment of glaucoma. Epinephrine, phenylephrine, or hydroxy-amphetamine which usually do not increase intraocular pressure are used in open angle glaucoma to reduce pressure by vasoconstrictive action. Pilocarpine acts directly upon the cholinergic receptor sites to mimic acetylcholine. Neostigmimine, methacholine, and bethanechol are usually contraindicated in narrow angle glaucoma. Acetazolamide is a carbonic anhydrase inhibitor and reduces the rate of secretion of aqueous humor.

However, many drugs used systemically or in the eye for purposes other than glaucoma do raise intraocular pressure and may precipitate acute glaucoma. Those, such as belladonna alkaloids are well known. Others, such as corticosteroids are prescribed for ophthalmic use or systemically, and their intraocular pressure-heightening effect is often overlooked. Often the problem is exacerbated in older people since many take belladonna or other anticholinergic agents, and they are particularly prone to experiencing a rise in intraocular pressure. These are

First Page Preview View Large
First page PDF preview
First page PDF preview
×